[go: up one dir, main page]

AT17300U3 - Feste orale pharmazeutische Zusammensetzung - Google Patents

Feste orale pharmazeutische Zusammensetzung Download PDF

Info

Publication number
AT17300U3
AT17300U3 ATGM113/2020U AT1132020U AT17300U3 AT 17300 U3 AT17300 U3 AT 17300U3 AT 1132020 U AT1132020 U AT 1132020U AT 17300 U3 AT17300 U3 AT 17300U3
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
solid oral
oral pharmaceutical
disintegrant
lubricant
Prior art date
Application number
ATGM113/2020U
Other languages
English (en)
Other versions
AT17300U2 (de
Original Assignee
G L Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by G L Pharma Gmbh filed Critical G L Pharma Gmbh
Priority to ATGM113/2020U priority Critical patent/AT17300U3/de
Publication of AT17300U2 publication Critical patent/AT17300U2/de
Publication of AT17300U3 publication Critical patent/AT17300U3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Feste orale pharmazeutische Zusammensetzung enthaltend Lurasidon oder ein pharmazeutisch annehmbares Salz davon, Stärke, Zuckeralkohol, ein Sprengmittel, und ein Schmiermittel.
ATGM113/2020U 2020-12-03 2020-12-03 Feste orale pharmazeutische Zusammensetzung AT17300U3 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ATGM113/2020U AT17300U3 (de) 2020-12-03 2020-12-03 Feste orale pharmazeutische Zusammensetzung

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ATGM113/2020U AT17300U3 (de) 2020-12-03 2020-12-03 Feste orale pharmazeutische Zusammensetzung

Publications (2)

Publication Number Publication Date
AT17300U2 AT17300U2 (de) 2021-12-15
AT17300U3 true AT17300U3 (de) 2022-02-15

Family

ID=78951103

Family Applications (1)

Application Number Title Priority Date Filing Date
ATGM113/2020U AT17300U3 (de) 2020-12-03 2020-12-03 Feste orale pharmazeutische Zusammensetzung

Country Status (1)

Country Link
AT (1) AT17300U3 (de)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1884242A1 (de) * 2005-05-26 2008-02-06 Dainippon Sumitomo Pharma Co., Ltd. Pharmazeutische zusammensetzung
EP1974724A2 (de) * 2000-09-22 2008-10-01 Dainippon Sumitomo Pharma Co., Ltd. Orale Zubereitungen mit guten Zerfallseigenschaften
CN103054824A (zh) * 2012-12-21 2013-04-24 北京万全德众医药生物技术有限公司 盐酸鲁拉西酮口崩片制剂及其制备方法
WO2016139683A2 (en) * 2015-03-05 2016-09-09 Jubilant Generics Limited Pharmaceutical compositions of lurasidone and process for preparing the same
CN106074414A (zh) * 2012-07-12 2016-11-09 成都康弘药业集团股份有限公司 一种含有鲁拉西酮的口腔崩解片及其制备方法
CN106539768A (zh) * 2015-09-18 2017-03-29 成都康弘药业集团股份有限公司 一种盐酸鲁拉西酮口腔崩解片及其制备方法

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1974724A2 (de) * 2000-09-22 2008-10-01 Dainippon Sumitomo Pharma Co., Ltd. Orale Zubereitungen mit guten Zerfallseigenschaften
EP1884242A1 (de) * 2005-05-26 2008-02-06 Dainippon Sumitomo Pharma Co., Ltd. Pharmazeutische zusammensetzung
CN106074414A (zh) * 2012-07-12 2016-11-09 成都康弘药业集团股份有限公司 一种含有鲁拉西酮的口腔崩解片及其制备方法
CN103054824A (zh) * 2012-12-21 2013-04-24 北京万全德众医药生物技术有限公司 盐酸鲁拉西酮口崩片制剂及其制备方法
WO2016139683A2 (en) * 2015-03-05 2016-09-09 Jubilant Generics Limited Pharmaceutical compositions of lurasidone and process for preparing the same
CN106539768A (zh) * 2015-09-18 2017-03-29 成都康弘药业集团股份有限公司 一种盐酸鲁拉西酮口腔崩解片及其制备方法

Also Published As

Publication number Publication date
AT17300U2 (de) 2021-12-15

Similar Documents

Publication Publication Date Title
ATE474561T1 (de) Orodispersible pharmazeutische zusammensetzung für die orale, oromukosale oder sublinguale verabreichung von agomelatin
WO2019060322A3 (en) HIGH DOSAGE VALBENAZINE FORMULATION AND COMPOSITIONS, METHODS AND KITS THEREOF
NO20084065L (no) Hurtig frigivelses paracetamol tabletter
AR109571A2 (es) Composición de trazodona para administración una vez por día
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
RS53570B1 (en) Dpp iv inhibitor formulations
EA200901393A1 (ru) Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат
HUP0303325A2 (hu) Gyógyászati sók és ezeket tartalmazó gyógyászati készítmények
JP2010047612A5 (de)
PE20110121A1 (es) Composiciones farmaceuticas de aliskiren
NO20080164L (no) N-(pyridin-2-yl)-sulfonamidderivater
IL168266A (en) Nucleoside derivatives, processes for their preparation. pharmaceutical compositions comprising them and uses thereof for the manufacture of medicaments
AR034691A1 (es) Composiciones farmaceuticas de administracion oral, que contiene un inhibidor de lipasa gastrointestinal, el comprimido masticable y la galleta que los comprende
CL2007002875A1 (es) Composicion farmaceutica recubierta por una pelicula que comprende capecitabina y al menos un disgregante, util en el tratamiento del cancer para pacientes que tienen dificultad para tragar las formas de dosificacion solidas orales.
NO20082047L (no) Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme
DE602004011398D1 (de) Direkt komprimierbare pharmazeutische zusammensetzung für die orale verabreichung von cci-779
AR069031A1 (es) Composicion
TNSN07337A1 (en) Pharmaceutical composition comprising an indolylmaleimide derivative
JOP20220093A1 (ar) تركيبة صيدلانية تشتمل على سيليكسيباغ
EA200500213A1 (ru) Диспергируемые таблетки для орального назначения
EP4122483A4 (de) Orale pharmazeutische zusammensetzung
PH12022552454A1 (en) Pharmaceutical composition for oral administration comprising aminopyrimidine derivative or pharmaceutically acceptable salt, hydrate, or solvate thereof
WO2019074826A3 (en) Bi-layer pharmaceutical tablet formulation
AT17300U3 (de) Feste orale pharmazeutische Zusammensetzung
SI1994926T1 (sl) Farmacevtske oblike valsartana